IFITM1 and myeloid sarcoma: Gene expression of IFIGs (IFI44L, IFITM1, G1P2, IFITM3, and Mx1) in peripheral blood cells was higher in MS than in healthy controls, suggesting an elevated IFN-I signature in MS patients [42].